Religare Health Insurance (RHI) recognized as one of the Brands making Healthcare Accessible

New Delhi: Religare Health Insurance (RHI), one of India’s leading Standalone Health Insurers was awarded ‘Health Access Brand’ at the Indian Health & Wellness Awards, 2018 for its product‘Grameen Care’ & its contribution towards achieving the vision of a healthy India.

‘Grameen Care’ reflects the organization’s endeavor to ensure that low & middle income group citizenry residing in tier-3 & rural markets have access to an affordable health insurance coverage which safeguards them against financial burden from any health adversity.

RHI’s initiative was not limited to product development but extended to identification & training healthcare centers at village/tehsil level to render cashless services to customers – a first-time experience for many beneficiaries.

Mr. Anuj Gulati, CEO and MD, Religare Health Insurance said, “The main strength of Grameen Care is that beneficiaries can avail cashless facility through a proximate network of able healthcare providers. It’s also specifically relevant as a credit protection instrument for customers of micro-finance institutions since it safeguards them from expenses arising out of a health adversity. We are pleased to have had successful implementation in key markets including Religare Health Insurance Himachal Pradesh, Jammu & Kashmir, among others. This award is recognition of the belief & faith our associates and customers repose in us.”

The organization has been adjudged the ‘Best Health Insurance Company’ at the ABP News-BFSI Awards & ‘Best Claims Service Leader of the Year – Insurance India Summit & Awards. Religare Health Insurance has also received the ‘Editor’s Choice Award for Best Product Innovation’ at Finnoviti and was conferred the ‘Best Medical Insurance Product Award’ at The FICCI Healthcare Awards.

Related Posts

Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

HC denies bail to pharma company owner for manufacturing spurious drugs

Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Illegally stocked drugs worth Rs 5.21 lakh seized

Illegally stocked drugs worth Rs 5.21 lakh seized

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions